BRAINSTORM CELL THERAPEUTICS INC.
BRAINSTORM CELL THERAPEUTICS INC.
Insider Sentiment (TTM):
Last Purchase:2024-10-01Last Sale:2024-07-19Shares Purchased (TTM):0Shares Sold (TTM):0
Institutional Sentiment:
As of:2025-09-30Institutional Shares Owned:2,164Shares Outstanding:11,008,047Institutional Ownership Pct.:0.02%
Earnings Market Reaction:
Filing Date:2026-05-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) — SEC Financial Statements & Analysis
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 3 | 1 | 1 | 1 | 1 | |||||
Short Term Investments | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Nontrade Receivables Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||||
Assets Current | 0 | 0 | 1 | 2 | 2 | 0 | 0 | 4 | 1 | 2 | 2 | 1 | |||||
Assets Noncurrent | |||||||||||||||||
Other Assets Noncurrent | - | 0 | 1 | 1 | 1 | 0 | 2 | 2 | 2 | 2 | 4 | 5 | |||||
Prepaid Expense And Other Assets Noncurrent | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |||||
Assets Noncurrent | 1 | 1 | - | - | - | 1 | - | - | - | - | - | - | |||||
Assets | 1 | 1 | 1 | 3 | 4 | 2 | 2 | 6 | 3 | 4 | 6 | 6 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 7 | 7 | 6 | 6 | 7 | 6 | 5 | 5 | 5 | 5 | 4 | 5 | |||||
Accrued Liabilities Current | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | |||||
Other Liabilities Current | - | - | - | - | - | 0 | - | - | - | 0 | - | - | |||||
Short Term Borrowings | 1 | 1 | 0 | 0 | 1 | 0 | - | - | - | - | - | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Employee Related Liabilities Current | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | - | - | |||||
Liabilities Current | 12 | 11 | 9 | 9 | 11 | 9 | 7 | 8 | 7 | 8 | 6 | 8 | |||||
Liabilities | 12 | 11 | 9 | 9 | 11 | 10 | 8 | 9 | 9 | 9 | 8 | 10 | |||||
Liabilities Noncurrent | |||||||||||||||||
Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | |||||
Shares Subject To Mandatory Redemption Settlement … | - | 0 | 0 | 0 | - | 0 | 1 | 1 | 2 | 1 | 0 | - | |||||
Liabilities Noncurrent | - | - | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 1 | 2 | 2 | |||||
Warrants And Rights Outstanding | - | 0 | - | - | - | 0 | - | - | - | - | - | - | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 228 | 227 | 227 | 226 | 222 | 219 | 218 | 218 | 213 | 210 | 207 | 204 | |||||
Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | |||||
Retained Earnings Accumulated Deficit | -239 | -237 | -235 | - | -230 | -227 | -224 | -221 | -218 | -215 | -209 | -208 | |||||
Stockholders Equity | -11 | -10 | -8 | -6 | -7 | -8 | -6 | -4 | -6 | -5 | -3 | -4 | |||||
Liabilities And Stockholders Equity | 1 | 1 | 1 | 3 | 4 | 2 | 2 | 6 | 3 | 4 | 6 | 6 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 750 | 750 | 750 | 750 | 750 | 800 | 750 | 800 | 800 | 800 | 800 | 800 | |||||
Common Stock Shares Issued | 11 | 11 | 11 | 10 | 8 | 6 | 5 | 80 | 68 | 81 | 91 | 82 | |||||
Shares Outstanding | 11 | 11 | 11 | 10 | 8 | 6 | 5 | 5 | 4 | 4 | 3 | 3 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.70% | 108.70% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 5.17% | 0.00% | -42.24% | 18.33% | 20.00% | 8.33% | -1.64% | 0.00% | 3.28% | -18.95% | -28.42% | -9.47% |
| 2024 | -18.00% | -26.00% | -36.00% | -16.13% | -49.89% | -60.00% | 40.71% | 97.35% | 61.06% | -22.22% | -14.29% | -3.17% |
| 2023 | - | - | - | -13.77% | -89.82% | -89.82% | 5.26% | 47.37% | 105.26% | -28.38% | -27.03% | -50.00% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.02 | 0.03 | 0.06 | 0.18 | 0.21 | 0.04 | 0.05 | 0.50 | 0.18 | 0.24 | 0.24 | 0.16 | |||||
| Quick Ratio | 0.01 | 0.01 | 0.01 | 0.11 | 0.16 | 0.03 | 0.03 | 0.46 | 0.12 | 0.17 | 0.23 | 0.11 | |||||
| Working Capital | -11.58M | -10.70M | -8.52M | -7.01M | -8.57M | -8.59M | -6.72M | -3.88M | -5.57M | -5.90M | -4.78M | -6.48M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.07 | -1.10 | -1.18 | -1.42 | -1.48 | -1.24 | -1.33 | -2.61 | -1.60 | -1.87 | -3.20 | -2.48 | |||||
| Interest Coverage TTM | -6.62 | -7.59 | -20.33 | -22.41 | -53.28 | -63.21 | -158.43 | -543.17 | - | - | - | - | |||||
| Debt Ratio | 15.58 | 10.77 | 6.57 | 3.36 | 3.09 | 5.24 | 3.99 | 1.62 | 2.66 | 2.15 | 1.45 | 1.68 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.87 | -1.11 | -0.99 | -1.33 | -1.75 | -2.31 | -2.68 | -2.68 | -3.60 | -5.99 | -5.64 | -6.73 | |||||
| Free Cash Flow Per Share TTM | -0.60 | -0.75 | -0.66 | -1.10 | -1.21 | -1.81 | -2.13 | -3.05 | -4.53 | -7.13 | -7.40 | -6.13 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | -13.67% | -11.32% | -23.77% | -10.18% | -28.63% | -32.39% | -14.45% | -42.75% | -35.21% | -29.18% | -34.65% | -6.95% | |||||
| EPS Growth (1Y) | -50.39% | -51.96% | -63.23% | -50.53% | -51.43% | -61.34% | -52.47% | -60.11% | -54.04% | -24.97% | -32.63% | -14.48% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -1.10 | -0.49 | -0.72 | -0.84 | -0.72 | -0.98 | -1.29 | -1.90 | -2.33 | -0.68 | -0.53 | -4.59 | |||||
| P/B | -0.95 | -0.51 | -1.02 | -1.59 | -1.07 | -1.47 | -3.02 | -6.87 | -6.53 | -2.39 | -3.43 | -26.33 | |||||
| Market Cap | 10.48M | 5.10M | 7.82M | 9.65M | 7.99M | 11.40M | 18.32M | 24.21M | 36.25M | 11.63M | 8.85M | 102.22M | |||||
| Enterprise Value | 11.61M | 5.79M | 7.68M | 8.73M | 7.36M | 11.33M | 17.97M | 20.57M | 35.29M | 10.15M | 7.63M | 101.67M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -6.66M | -6.98M | -7.28M | -9.48M | -7.66M | -9.09M | -11.33M | -14.46M | -19.55M | -20.48M | -21.84M | -20.26M | |||||
| Net Debt | 1.12M | 691.00K | -135.00K | -924.00K | -626.00K | -71.00K | -349.00K | -3.65M | -961.00K | -1.49M | -1.22M | -546.00K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2024-10-01Purchase
Owner: Lebovits, Chaim
Title: President & CEO
Shares: 1,836
Price/Share: $3.43
Value: $6,297.48
Shares Owned: 80,960
Relationship: Officer
Ownership: Direct
2024-07-19Sale
Owner: Dagher, Ibrahim B.
Title: Chief Medical Officer
Shares: 63,000
Price/Share: $0.35
Value: $22,050.00
Shares Owned: -
Relationship: Officer
Ownership: Direct
2024-05-28Purchase
Owner: Lebovits, Chaim
Title: President & CEO
Shares: 15,000
Price/Share: $0.52
Value: $7,800.00
Shares Owned: 1,164,865
Relationship: Officer
Ownership: Direct
2024-05-22Purchase
Owner: Lebovits, Chaim
Title: President & CEO
Shares: 25,000
Price/Share: $0.64
Value: $16,000.00
Shares Owned: 1,149,865
Relationship: Officer
Ownership: Direct
2024-05-13Purchase
Owner: Lebovits, Chaim
Title: President & CEO
Shares: 10,000
Price/Share: $0.49
Value: $4,900.00
Shares Owned: 1,099,865
Relationship: Officer
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2025-09-30
0.02%
Inst. Shares: 2,164
Shares Outstanding: 11,008,047
2025-06-30
2.74%
Inst. Shares: 235,788
Shares Outstanding: 8,620,400
2025-03-31
13.65%
Inst. Shares: 865,688
Shares Outstanding: 6,342,002
2024-12-31
4.69%
Inst. Shares: 235,516
Shares Outstanding: 5,021,798
2024-09-30
203.43%
Inst. Shares: 10,801,873
Shares Outstanding: 5,309,796